Christopher M. Locke, Member of the Firm in the Health Care & Life Sciences practice, in the firm’s Washington, DC, office, was featured in The Washington Business Journal, Thompson Reuters WestLaw, The Global Legal Chronicle, Reuters, POLITICO, and Attorney at Law Magazine.
Following are excerpts:
The Washington Business Journal, “Christopher Locke, Hired at Epstein Becker Green.”
Epstein Becker Green welcomes health care transactional attorney Christopher M. Locke to its Washington, D.C., office and Health Care and Life Sciences practice. With decades of experience guiding professional practices, hospital systems, and private equity-backed entities through complex partnerships, acquisitions, and joint ventures, Locke brings deep regulatory acumen to the firm's growing transactional capabilities. He rejoins Epstein Becker Green after two previous stints at the firm.
Thompson Reuters WestLaw, “Epstein Becker Green Rehires Transactional Attorney in Washington. D.C.,” by Noemie Sandoval.
Transactional attorney Christopher M. Locke has returned to Epstein Becker & Green PC after a 10-year stint with Katten Muchin Rosenman LLP.
Locke serves as member of the firm as part of its health care and life sciences practice. ...
The Global Legal Chronicle, “Health Care Transactional Attorney Christopher M. Locke Joins Epstein Becker Green in Washington, DC,” by Leila Ahmed.
Epstein Becker Green announced that transactional attorney Christopher M. Locke has rejoined the firm’s Health Care and Life Sciences practice as a Member of the Firm in Washington, DC. Locke brings more than 25 years of experience guiding professional practices, hospital systems, and private equity-backed entities through complex health care transactions and regulatory compliance matters.
As private equity investments in the health care sector continue to expand at a rapid pace, with 2025 disclosed deal value exceeding an estimated $191 billion, the industry faces an increasingly complex web of regulatory review and consolidation.
Chris rejoins Epstein Becker Green after a decade-long stint at a large national law firm.
“Chris brings a level of transactional and strategic insight that is increasingly critical for our clients as they navigate shifting reimbursement models, regulatory scrutiny, and a trend towards consolidation,” said Mark Lutes, Chair of Epstein Becker Green’s Board of Directors. “We are pleased with his decision to return to Epstein Becker Green and fortunate to deepen our bench and capabilities related to complex transactions with his arrival.”
Reuters, “The Afternoon Docket,” by Caitlin Tremblay.
Christopher Locke rejoined Epstein Becker Green as partner in its healthcare and life sciences practice from Katten Muchin Rosenman.
POLITICO, “POLITICO Playbook,” by Irie Sentner and Makayla Gray.
Christopher Locke has rejoined Epstein Becker Green as a member in the firm’s health care and life sciences practice. He previously was at Katten Muchin Rosenman.
